MyoKardia

Bristol-Myers to Buy MyoKardia for $13B
M&A

Bristol-Myers to Buy MyoKardia for $13B

The deal helps expand the pharma giant's portfolio of heart disease treatments.
By Lauren Muskett | October 5, 2020
Read More